Rina K Patel
About
In The Last Decade
Rina K Patel
9 papers receiving 335 citations
Peers
Comparison fields: 5 of 68
- Oncology 134
- Pulmonary and Respiratory Medicine 114
- Immunology 60
- Molecular Biology 58
- Biotechnology 51
Countries citing papers authored by Rina K Patel
This map shows the geographic impact of Rina K Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina K Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina K Patel more than expected).
Fields of papers citing papers by Rina K Patel
This network shows the impact of papers produced by Rina K Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina K Patel. The network helps show where Rina K Patel may publish in the future.
Co-authorship network of co-authors of Rina K Patel
This figure shows the co-authorship network connecting the top 25 collaborators of Rina K Patel. A scholar is included among the top collaborators of Rina K Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina K Patel. Rina K Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 19 | |
| 4 | 6 | |
| 5 | 16 | |
| 6 | Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines. | 33 |
| 7 | Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. | 155 |
| 8 | Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. | 113 |
| 9 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.